FDA has issued 1,284 breakthrough device designations. Medicare is not obligated to pay for a single one. That gap has now produced three separate federal policy attempts in five years.
The first attempt, Medicare Coverage of Innovative Technology, promised automatic national coverage the day FDA authorized a breakthrough device. It was repealed in Novem…
